Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, Prognosis Impact, and Methotrexate Cytotoxicity.

Nadia El MenshawyAhmed B El MarghanyMohamed M SarhanDoaa A Aladle

Published in: Asian Pacific journal of cancer prevention : APJCP (2020)

Our results suggested that CCND1 G870A polymorphism is associated with a high risk of ALL development. However, it has no role in ALL prognosis or methotrexate cytotoxicity.

Keyphrases

high dose
cell death
signaling pathway